Skip to main content
. 2021 Jun 3;23(8):1313–1321. doi: 10.1002/ejhf.2221

Figure 1.

EJHF-2221-FIG-0001-c

Change in serum creatinine (A) and estimated glomerular filtration rate (eGFR, B) over time in vericiguat‐ and placebo‐treated patients was assessed with a linear mixed model. This figure shows no differences in the change in creatinine (P = 0.18) and eGFR (P = 0.50) between the vericiguat and placebo groups, as evaluated by the interaction between treatment and study visit in the model.